You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KYMR Exercise Disclosure
Mainolfi Nello · SEC Form 4 · Filed Oct 1, 2026
Exercise
Calculated transaction value
$0
Mainolfi Nello Chief Executive Officer
KYMR
Kymera Therapeutics
KYMR
Transaction date
Oct 1, 2026
Public filing date
Oct 1, 2026
Filing lag
Filed same day
KYMR daily price context
Close on/before transaction
$110.12
Oct 1, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 30,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-410839
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$3.48M
Buys / sales
0 / 6
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Kymera Therapeutics, Inc. KYMR | Exercise | Oct 1, 2026 | $62.4K |
| Kymera Therapeutics, Inc. KYMR | Sale | Oct 1, 2026 | $392.83K |
| Kymera Therapeutics, Inc. KYMR | Sale | Oct 1, 2026 | $618.98K |
| Kymera Therapeutics, Inc. KYMR | Sale | Oct 1, 2026 | $869.78K |
| Kymera Therapeutics, Inc. KYMR | Sale | Oct 1, 2026 | $949.74K |
| Kymera Therapeutics, Inc. KYMR | Sale | Oct 1, 2026 | $30.42K |
| Kymera Therapeutics, Inc. KYMR Current | Exercise | Oct 1, 2026 | $0 |
| Kymera Therapeutics, Inc. KYMR | Sale | Oct 1, 2026 | $552.16K |